Share Price and Basic Stock Data
Last Updated: April 3, 2025, 1:35 am
PEG Ratio | -7.32 |
---|
Competitors of DCM Shriram Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
NESCO Ltd | 6,628 Cr. | 943 | 1,082/780 | 16.9 | 345 | 0.64 % | 22.4 % | 17.0 % | 2.00 |
DCM Shriram Ltd | 16,742 Cr. | 1,078 | 1,371/885 | 30.8 | 426 | 0.61 % | 8.99 % | 6.60 % | 2.00 |
Balmer Lawrie & Company Ltd | 3,249 Cr. | 190 | 320/147 | 12.5 | 104 | 4.47 % | 15.6 % | 14.7 % | 10.0 |
3M India Ltd | 32,207 Cr. | 28,671 | 41,000/25,714 | 52.7 | 1,906 | 0.56 % | 40.5 % | 30.5 % | 10.0 |
Industry Average | 14,706.50 Cr | 7,720.50 | 28.23 | 695.25 | 1.57% | 21.87% | 17.20% | 6.00 |
Quarterly Result
Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 2,791 | 2,873 | 2,851 | 2,740 | 3,236 | 2,720 | 2,780 | 2,708 | 3,035 | 2,399 | 2,876 | 2,957 | 3,367 |
Expenses | 2,202 | 2,239 | 2,415 | 2,470 | 2,682 | 2,374 | 2,614 | 2,594 | 2,590 | 2,134 | 2,629 | 2,776 | 2,871 |
Operating Profit | 589 | 635 | 436 | 270 | 554 | 346 | 166 | 114 | 445 | 265 | 248 | 181 | 496 |
OPM % | 21% | 22% | 15% | 10% | 17% | 13% | 6% | 4% | 15% | 11% | 9% | 6% | 15% |
Other Income | 25 | 28 | 28 | 32 | 33 | 26 | 17 | 22 | 35 | 24 | 26 | 54 | 41 |
Interest | 17 | 17 | 17 | 11 | 13 | 12 | 25 | 15 | 15 | 32 | 29 | 38 | 43 |
Depreciation | 61 | 61 | 61 | 63 | 66 | 71 | 72 | 74 | 77 | 80 | 86 | 101 | 109 |
Profit before tax | 536 | 585 | 387 | 228 | 509 | 289 | 86 | 47 | 389 | 177 | 158 | 96 | 386 |
Tax % | 35% | 31% | 34% | 44% | 33% | 35% | 34% | 32% | 38% | 33% | 37% | 34% | 32% |
Net Profit | 350 | 401 | 254 | 128 | 342 | 187 | 57 | 32 | 240 | 118 | 100 | 63 | 262 |
EPS in Rs | 22.43 | 25.73 | 16.29 | 8.22 | 21.94 | 11.97 | 3.63 | 2.07 | 15.42 | 7.55 | 6.43 | 4.03 | 16.81 |
Last Updated: March 3, 2025, 4:49 pm
Below is a detailed analysis of the quarterly data for DCM Shriram Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹3,367.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,957.00 Cr. (Sep 2024) to ₹3,367.00 Cr., marking an increase of 410.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹2,871.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,776.00 Cr. (Sep 2024) to ₹2,871.00 Cr., marking an increase of 95.00 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹496.00 Cr.. The value appears strong and on an upward trend. It has increased from 181.00 Cr. (Sep 2024) to ₹496.00 Cr., marking an increase of 315.00 Cr..
- For OPM %, as of Dec 2024, the value is 15.00%. The value appears strong and on an upward trend. It has increased from 6.00% (Sep 2024) to 15.00%, marking an increase of 9.00%.
- For Other Income, as of Dec 2024, the value is ₹41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 54.00 Cr. (Sep 2024) to ₹41.00 Cr., marking a decrease of 13.00 Cr..
- For Interest, as of Dec 2024, the value is ₹43.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 38.00 Cr. (Sep 2024) to ₹43.00 Cr., marking an increase of 5.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹109.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 101.00 Cr. (Sep 2024) to ₹109.00 Cr., marking an increase of 8.00 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹386.00 Cr.. The value appears strong and on an upward trend. It has increased from 96.00 Cr. (Sep 2024) to ₹386.00 Cr., marking an increase of 290.00 Cr..
- For Tax %, as of Dec 2024, the value is 32.00%. The value appears to be improving (decreasing) as expected. It has decreased from 34.00% (Sep 2024) to 32.00%, marking a decrease of 2.00%.
- For Net Profit, as of Dec 2024, the value is ₹262.00 Cr.. The value appears strong and on an upward trend. It has increased from 63.00 Cr. (Sep 2024) to ₹262.00 Cr., marking an increase of 199.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is 16.81. The value appears strong and on an upward trend. It has increased from 4.03 (Sep 2024) to 16.81, marking an increase of 12.78.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 4:29 pm
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 5,539 | 6,182 | 5,639 | 5,780 | 5,788 | 6,900 | 7,771 | 7,767 | 8,308 | 9,627 | 11,547 | 10,922 | 11,600 |
Expenses | 4,999 | 5,673 | 5,240 | 5,276 | 5,017 | 5,866 | 6,402 | 6,575 | 7,156 | 7,831 | 9,941 | 9,932 | 10,410 |
Operating Profit | 540 | 509 | 399 | 505 | 771 | 1,035 | 1,369 | 1,192 | 1,152 | 1,796 | 1,606 | 991 | 1,190 |
OPM % | 10% | 8% | 7% | 9% | 13% | 15% | 18% | 15% | 14% | 19% | 14% | 9% | 10% |
Other Income | -20 | 50 | 52 | 41 | 47 | 56 | 88 | 88 | 92 | 92 | 120 | 99 | 145 |
Interest | 155 | 149 | 112 | 85 | 71 | 83 | 119 | 164 | 122 | 85 | 53 | 88 | 143 |
Depreciation | 147 | 138 | 110 | 98 | 114 | 141 | 157 | 219 | 233 | 238 | 260 | 303 | 376 |
Profit before tax | 219 | 272 | 228 | 362 | 633 | 867 | 1,180 | 897 | 889 | 1,565 | 1,413 | 699 | 816 |
Tax % | 7% | 11% | 8% | 17% | 13% | 23% | 24% | 20% | 24% | 32% | 36% | 36% | |
Net Profit | 203 | 242 | 211 | 301 | 552 | 669 | 904 | 722 | 674 | 1,067 | 911 | 447 | 543 |
EPS in Rs | 12.23 | 14.85 | 12.98 | 18.58 | 33.97 | 41.22 | 56.99 | 45.96 | 43.17 | 68.45 | 58.41 | 28.67 | 34.82 |
Dividend Payout % | 13% | 14% | 17% | 17% | 17% | 20% | 17% | 18% | 22% | 22% | 24% | 23% |
YoY Net Profit Growth
Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 19.21% | -12.81% | 42.65% | 83.39% | 21.20% | 35.13% | -20.13% | -6.65% | 58.31% | -14.62% | -50.93% |
Change in YoY Net Profit Growth (%) | 0.00% | -32.02% | 55.46% | 40.73% | -62.19% | 13.93% | -55.26% | 13.48% | 64.96% | -72.93% | -36.31% |
DCM Shriram Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 6% |
5 Years: | 7% |
3 Years: | 10% |
TTM: | 3% |
Compounded Profit Growth | |
---|---|
10 Years: | 6% |
5 Years: | -14% |
3 Years: | -14% |
TTM: | 5% |
Stock Price CAGR | |
---|---|
10 Years: | 24% |
5 Years: | 39% |
3 Years: | -3% |
1 Year: | 15% |
Return on Equity | |
---|---|
10 Years: | 17% |
5 Years: | 15% |
3 Years: | 14% |
Last Year: | 7% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 15, 2024, 12:38 am
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 33 | 33 | 33 | 33 | 33 | 33 | 31 | 31 | 31 | 31 | 31 | 31 | 31 |
Reserves | 1,462 | 1,654 | 1,826 | 2,058 | 2,495 | 3,007 | 3,494 | 4,018 | 4,617 | 5,470 | 6,162 | 6,491 | 6,611 |
Borrowings | 1,557 | 1,177 | 760 | 1,064 | 1,074 | 756 | 1,610 | 2,150 | 1,521 | 1,577 | 1,707 | 2,152 | 2,203 |
Other Liabilities | 1,699 | 1,988 | 1,798 | 1,852 | 1,972 | 1,857 | 2,001 | 1,935 | 1,621 | 2,290 | 2,819 | 2,874 | 3,255 |
Total Liabilities | 4,751 | 4,852 | 4,417 | 5,007 | 5,574 | 5,652 | 7,136 | 8,135 | 7,790 | 9,369 | 10,720 | 11,547 | 12,101 |
Fixed Assets | 1,565 | 1,513 | 1,443 | 1,428 | 2,022 | 2,211 | 2,690 | 3,499 | 3,360 | 3,408 | 4,105 | 4,222 | 5,974 |
CWIP | 44 | 51 | 62 | 357 | 65 | 117 | 332 | 59 | 109 | 494 | 1,630 | 2,615 | 1,188 |
Investments | 7 | 203 | 6 | 35 | 31 | 30 | 31 | 29 | 30 | 3 | 12 | 54 | 54 |
Other Assets | 3,134 | 3,085 | 2,906 | 3,186 | 3,457 | 3,294 | 4,084 | 4,548 | 4,291 | 5,463 | 4,973 | 4,656 | 4,885 |
Total Assets | 4,751 | 4,852 | 4,417 | 5,007 | 5,574 | 5,652 | 7,136 | 8,135 | 7,790 | 9,369 | 10,720 | 11,547 | 12,101 |
Below is a detailed analysis of the balance sheet data for DCM Shriram Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹31.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 31.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹6,611.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,491.00 Cr. (Mar 2024) to ₹6,611.00 Cr., marking an increase of 120.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹2,203.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 2,152.00 Cr. (Mar 2024) to ₹2,203.00 Cr., marking an increase of 51.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹3,255.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,874.00 Cr. (Mar 2024) to ₹3,255.00 Cr., marking an increase of 381.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹12,101.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11,547.00 Cr. (Mar 2024) to ₹12,101.00 Cr., marking an increase of 554.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹5,974.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,222.00 Cr. (Mar 2024) to ₹5,974.00 Cr., marking an increase of 1,752.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹1,188.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,615.00 Cr. (Mar 2024) to ₹1,188.00 Cr., marking a decrease of 1,427.00 Cr..
- For Investments, as of Sep 2024, the value is ₹54.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 54.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹4,885.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,656.00 Cr. (Mar 2024) to ₹4,885.00 Cr., marking an increase of 229.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹12,101.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,547.00 Cr. (Mar 2024) to ₹12,101.00 Cr., marking an increase of 554.00 Cr..
Notably, the Reserves (₹6,611.00 Cr.) exceed the Borrowings (2,203.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 539.00 | 508.00 | -361.00 | 504.00 | 770.00 | -755.00 | 0.00 | -1.00 | 0.00 | 0.00 | 0.00 | 989.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 68 | 61 | 69 | 81 | 63 | 48 | 49 | 51 | 23 | 34 | 27 | 22 |
Inventory Days | 148 | 105 | 120 | 141 | 194 | 163 | 190 | 208 | 146 | 190 | 153 | 168 |
Days Payable | 114 | 120 | 119 | 123 | 138 | 110 | 113 | 89 | 57 | 79 | 65 | 65 |
Cash Conversion Cycle | 102 | 47 | 71 | 100 | 120 | 100 | 126 | 170 | 111 | 145 | 115 | 124 |
Working Capital Days | 85 | 46 | 65 | 77 | 67 | 64 | 73 | 102 | 64 | 67 | 52 | 58 |
ROCE % | 14% | 14% | 12% | 15% | 21% | 25% | 29% | 19% | 16% | 24% | 19% | 9% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
Tata Equity P/E Fund - Regular Plan | 512,612 | 0.92 | 55.85 | 461 | 2025-04-02 | 111095.66% |
Tata Equity P/E Fund - Regular Plan - Trigger Option A 5% | 512,612 | 0.92 | 55.85 | 461 | 2025-04-02 | 111095.66% |
Nippon India Nifty Smallcap 250 Index Fund | 29,218 | 0.38 | 2.71 | 461 | 2025-04-02 | 6237.96% |
ICICI Prudential Nifty Smallcap 250 Index Fund | 6,848 | 0.43 | 0.75 | 461 | 2025-04-02 | 1385.47% |
HDFC NIFTY Smallcap 250 ETF | 3,127 | 0.43 | 0.34 | 461 | 2025-04-02 | 578.31% |
HDFC Nifty Smallcap 250 Index Fund | 2,425 | 0.43 | 0.26 | 461 | 2025-04-02 | 426.03% |
ICICI Prudential S&P BSE 500 ETF | 461 | 0.04 | 0.05 | 461 | 2025-04-02 | 0% |
HDFC S&P BSE 500 Index Fund | 64 | 0.04 | 0.01 | 461 | 2025-04-02 | -86.12% |
HDFC S&P BSE 500 ETF | 25 | 0.04 | 0 | 461 | 2025-04-02 | -94.58% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Basic EPS (Rs.) | 28.67 | 58.41 | 68.45 | 43.17 | 46.91 |
Diluted EPS (Rs.) | 28.67 | 58.41 | 68.45 | 43.17 | 45.96 |
Cash EPS (Rs.) | 47.85 | 74.70 | 83.19 | 57.76 | 59.87 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 416.08 | 395.14 | 350.99 | 296.53 | 258.75 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 416.08 | 395.14 | 350.99 | 296.53 | 258.75 |
Revenue From Operations / Share (Rs.) | 696.81 | 736.65 | 614.19 | 530.03 | 495.51 |
PBDIT / Share (Rs.) | 69.49 | 110.12 | 120.47 | 79.39 | 82.61 |
PBIT / Share (Rs.) | 50.16 | 93.52 | 105.29 | 64.51 | 68.63 |
PBT / Share (Rs.) | 44.58 | 90.15 | 99.84 | 56.73 | 57.24 |
Net Profit / Share (Rs.) | 28.52 | 58.11 | 68.01 | 42.89 | 45.90 |
NP After MI And SOA / Share (Rs.) | 28.52 | 58.11 | 68.09 | 42.96 | 45.72 |
PBDIT Margin (%) | 9.97 | 14.94 | 19.61 | 14.97 | 16.67 |
PBIT Margin (%) | 7.19 | 12.69 | 17.14 | 12.17 | 13.85 |
PBT Margin (%) | 6.39 | 12.23 | 16.25 | 10.70 | 11.55 |
Net Profit Margin (%) | 4.09 | 7.88 | 11.07 | 8.09 | 9.26 |
NP After MI And SOA Margin (%) | 4.09 | 7.88 | 11.08 | 8.10 | 9.22 |
Return on Networth / Equity (%) | 6.85 | 14.70 | 19.40 | 14.48 | 17.69 |
Return on Capital Employeed (%) | 8.95 | 17.97 | 23.60 | 16.93 | 19.96 |
Return On Assets (%) | 3.87 | 8.49 | 11.39 | 8.64 | 8.80 |
Long Term Debt / Equity (X) | 0.21 | 0.18 | 0.17 | 0.21 | 0.24 |
Total Debt / Equity (X) | 0.31 | 0.26 | 0.27 | 0.27 | 0.50 |
Asset Turnover Ratio (%) | 0.98 | 1.15 | 1.11 | 1.03 | 1.00 |
Current Ratio (X) | 1.62 | 1.84 | 2.18 | 2.29 | 1.61 |
Quick Ratio (X) | 0.64 | 0.90 | 1.21 | 1.30 | 0.81 |
Inventory Turnover Ratio (X) | 2.09 | 2.04 | 1.92 | 1.68 | 1.61 |
Dividend Payout Ratio (NP) (%) | 26.50 | 26.19 | 19.86 | -12.73 | 21.32 |
Dividend Payout Ratio (CP) (%) | 15.80 | 20.37 | 16.24 | -9.46 | 16.33 |
Earning Retention Ratio (%) | 73.50 | 73.81 | 80.14 | 0.00 | 78.68 |
Cash Earning Retention Ratio (%) | 84.20 | 79.63 | 83.76 | 0.00 | 83.67 |
Interest Coverage Ratio (X) | 12.44 | 32.69 | 22.12 | 10.20 | 7.90 |
Interest Coverage Ratio (Post Tax) (X) | 6.11 | 18.25 | 13.49 | 6.51 | 5.48 |
Enterprise Value (Cr.) | 14894.61 | 12389.38 | 17624.91 | 7800.09 | 4862.87 |
EV / Net Operating Revenue (X) | 1.36 | 1.07 | 1.83 | 0.93 | 0.62 |
EV / EBITDA (X) | 13.67 | 7.18 | 9.33 | 6.27 | 3.76 |
MarketCap / Net Operating Revenue (X) | 1.23 | 1.02 | 1.84 | 0.94 | 0.43 |
Retention Ratios (%) | 73.49 | 73.80 | 80.13 | 0.00 | 78.67 |
Price / BV (X) | 2.07 | 1.89 | 3.22 | 1.69 | 0.83 |
Price / Net Operating Revenue (X) | 1.23 | 1.02 | 1.84 | 0.94 | 0.43 |
EarningsYield | 0.03 | 0.07 | 0.06 | 0.08 | 0.21 |
After reviewing the key financial ratios for DCM Shriram Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 28.67. This value is within the healthy range. It has decreased from 58.41 (Mar 23) to 28.67, marking a decrease of 29.74.
- For Diluted EPS (Rs.), as of Mar 24, the value is 28.67. This value is within the healthy range. It has decreased from 58.41 (Mar 23) to 28.67, marking a decrease of 29.74.
- For Cash EPS (Rs.), as of Mar 24, the value is 47.85. This value is within the healthy range. It has decreased from 74.70 (Mar 23) to 47.85, marking a decrease of 26.85.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 416.08. It has increased from 395.14 (Mar 23) to 416.08, marking an increase of 20.94.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 416.08. It has increased from 395.14 (Mar 23) to 416.08, marking an increase of 20.94.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 696.81. It has decreased from 736.65 (Mar 23) to 696.81, marking a decrease of 39.84.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 69.49. This value is within the healthy range. It has decreased from 110.12 (Mar 23) to 69.49, marking a decrease of 40.63.
- For PBIT / Share (Rs.), as of Mar 24, the value is 50.16. This value is within the healthy range. It has decreased from 93.52 (Mar 23) to 50.16, marking a decrease of 43.36.
- For PBT / Share (Rs.), as of Mar 24, the value is 44.58. This value is within the healthy range. It has decreased from 90.15 (Mar 23) to 44.58, marking a decrease of 45.57.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 28.52. This value is within the healthy range. It has decreased from 58.11 (Mar 23) to 28.52, marking a decrease of 29.59.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 28.52. This value is within the healthy range. It has decreased from 58.11 (Mar 23) to 28.52, marking a decrease of 29.59.
- For PBDIT Margin (%), as of Mar 24, the value is 9.97. This value is below the healthy minimum of 10. It has decreased from 14.94 (Mar 23) to 9.97, marking a decrease of 4.97.
- For PBIT Margin (%), as of Mar 24, the value is 7.19. This value is below the healthy minimum of 10. It has decreased from 12.69 (Mar 23) to 7.19, marking a decrease of 5.50.
- For PBT Margin (%), as of Mar 24, the value is 6.39. This value is below the healthy minimum of 10. It has decreased from 12.23 (Mar 23) to 6.39, marking a decrease of 5.84.
- For Net Profit Margin (%), as of Mar 24, the value is 4.09. This value is below the healthy minimum of 5. It has decreased from 7.88 (Mar 23) to 4.09, marking a decrease of 3.79.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 4.09. This value is below the healthy minimum of 8. It has decreased from 7.88 (Mar 23) to 4.09, marking a decrease of 3.79.
- For Return on Networth / Equity (%), as of Mar 24, the value is 6.85. This value is below the healthy minimum of 15. It has decreased from 14.70 (Mar 23) to 6.85, marking a decrease of 7.85.
- For Return on Capital Employeed (%), as of Mar 24, the value is 8.95. This value is below the healthy minimum of 10. It has decreased from 17.97 (Mar 23) to 8.95, marking a decrease of 9.02.
- For Return On Assets (%), as of Mar 24, the value is 3.87. This value is below the healthy minimum of 5. It has decreased from 8.49 (Mar 23) to 3.87, marking a decrease of 4.62.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.21. This value is within the healthy range. It has increased from 0.18 (Mar 23) to 0.21, marking an increase of 0.03.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.31. This value is within the healthy range. It has increased from 0.26 (Mar 23) to 0.31, marking an increase of 0.05.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.98. It has decreased from 1.15 (Mar 23) to 0.98, marking a decrease of 0.17.
- For Current Ratio (X), as of Mar 24, the value is 1.62. This value is within the healthy range. It has decreased from 1.84 (Mar 23) to 1.62, marking a decrease of 0.22.
- For Quick Ratio (X), as of Mar 24, the value is 0.64. This value is below the healthy minimum of 1. It has decreased from 0.90 (Mar 23) to 0.64, marking a decrease of 0.26.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.09. This value is below the healthy minimum of 4. It has increased from 2.04 (Mar 23) to 2.09, marking an increase of 0.05.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 26.50. This value is within the healthy range. It has increased from 26.19 (Mar 23) to 26.50, marking an increase of 0.31.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 15.80. This value is below the healthy minimum of 20. It has decreased from 20.37 (Mar 23) to 15.80, marking a decrease of 4.57.
- For Earning Retention Ratio (%), as of Mar 24, the value is 73.50. This value exceeds the healthy maximum of 70. It has decreased from 73.81 (Mar 23) to 73.50, marking a decrease of 0.31.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 84.20. This value exceeds the healthy maximum of 70. It has increased from 79.63 (Mar 23) to 84.20, marking an increase of 4.57.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 12.44. This value is within the healthy range. It has decreased from 32.69 (Mar 23) to 12.44, marking a decrease of 20.25.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 6.11. This value is within the healthy range. It has decreased from 18.25 (Mar 23) to 6.11, marking a decrease of 12.14.
- For Enterprise Value (Cr.), as of Mar 24, the value is 14,894.61. It has increased from 12,389.38 (Mar 23) to 14,894.61, marking an increase of 2,505.23.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.36. This value is within the healthy range. It has increased from 1.07 (Mar 23) to 1.36, marking an increase of 0.29.
- For EV / EBITDA (X), as of Mar 24, the value is 13.67. This value is within the healthy range. It has increased from 7.18 (Mar 23) to 13.67, marking an increase of 6.49.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.23. This value is within the healthy range. It has increased from 1.02 (Mar 23) to 1.23, marking an increase of 0.21.
- For Retention Ratios (%), as of Mar 24, the value is 73.49. This value exceeds the healthy maximum of 70. It has decreased from 73.80 (Mar 23) to 73.49, marking a decrease of 0.31.
- For Price / BV (X), as of Mar 24, the value is 2.07. This value is within the healthy range. It has increased from 1.89 (Mar 23) to 2.07, marking an increase of 0.18.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.23. This value is within the healthy range. It has increased from 1.02 (Mar 23) to 1.23, marking an increase of 0.21.
- For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 23) to 0.03, marking a decrease of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in DCM Shriram Ltd:
- Net Profit Margin: 4.09%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.95% (Industry Average ROCE: 21.87%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.85% (Industry Average ROE: 17.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 6.11
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.64
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 30.8 (Industry average Stock P/E: 28.23)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.31
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.09%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Diversified | 2nd Floor (West Wing), New Delhi Delhi 110037 | response@dcmshriram.com http://www.dcmshriram.com |
Management | |
---|---|
Name | Position Held |
Mr. Ajay S Shriram | Chairman & Sr.Mng.Director |
Mr. Vikram S Shriram | Vice Chairman & Mng.Director |
Mr. Ajit S Shriram | Joint Managing Director |
Mr. Aditya A Shriram | Deputy Managing Director |
Mr. K K Sharma | Whole Time Director |
Mr. Pradeep Dinodia | Ind. Non-Executive Director |
Mr. Sunil Kant Munjal | Ind. Non-Executive Director |
Mr. Vimal Bhandari | Ind. Non-Executive Director |
Ms. Ramni Nirula | Ind. Non-Executive Director |
Mr. Pravesh Sharma | Ind. Non-Executive Director |
Justice(Retd) Vikramajit Sen | Ind. Non-Executive Director |
Mr. Rabinarayan Mishra | Nominee Director |
FAQ
What is the intrinsic value of DCM Shriram Ltd?
DCM Shriram Ltd's intrinsic value (as of 03 April 2025) is ₹697.00 — 35.34% lower the current market price of ₹1,078.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 16,742 Cr. market cap, FY2025-2026 high/low of ₹1,371/885, reserves of 6,611 Cr, and liabilities of 12,101 Cr.
What is the Market Cap of DCM Shriram Ltd?
The Market Cap of DCM Shriram Ltd is 16,742 Cr..
What is the current Stock Price of DCM Shriram Ltd as on 03 April 2025?
The current stock price of DCM Shriram Ltd as on 03 April 2025 is 1,078.
What is the High / Low of DCM Shriram Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of DCM Shriram Ltd stocks is ₹1,371/885.
What is the Stock P/E of DCM Shriram Ltd?
The Stock P/E of DCM Shriram Ltd is 30.8.
What is the Book Value of DCM Shriram Ltd?
The Book Value of DCM Shriram Ltd is 426.
What is the Dividend Yield of DCM Shriram Ltd?
The Dividend Yield of DCM Shriram Ltd is 0.61 %.
What is the ROCE of DCM Shriram Ltd?
The ROCE of DCM Shriram Ltd is 8.99 %.
What is the ROE of DCM Shriram Ltd?
The ROE of DCM Shriram Ltd is 6.60 %.
What is the Face Value of DCM Shriram Ltd?
The Face Value of DCM Shriram Ltd is 2.00.